Priorities

null
F.D.A. Approves Pill to Treat Hepatitis C

Health

F.D.A. Approves Pill to Treat Hepatitis C

by The Daily Eye Team December 10 2013, 3:30 pm Estimated Reading Time: 0 mins, 10 secs

The Food and Drug Administration has approved Sovaldi, from Gilead Sciences, which will let some patients be treated for a minimum of 12 weeks, but at a cost of $1,000 per daily pill. Click here to know more



Disclaimer: The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of thedailyeye.info. The writers are solely responsible for any claims arising out of the contents of this article.

Health

You May Also Like

XBB1.16 VARIANT– THE NEW SUPER SPREADER

2023-04-04 00:00:00

MASKS ON, CARRY ON

2022-12-27 00:00:00

Looking after a Family’s Medical Needs

2022-10-05 00:00:00

HOW TO PREVENT MONKEYPOX

2022-08-03 00:00:00

SAFELY NAVIGATING THE FOURTH SURGE

2022-06-28 00:00:00

What ails medical education in India?

2022-05-04 00:00:00

All you wanted to know about Omicron

2021-12-10 00:00:00

Kaizzad Capadia: The soul of fitness training

2021-10-28 00:00:00